NCT06641869View on ClinicalTrials.gov

Study of PCC1 for Skin Rejuvenation

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

February 23, 2024

Study Completion Date

August 10, 2024

Conditions
Skin Rejuvenation
Interventions
DIETARY_SUPPLEMENT

procyanidin C1

Proprietarily extracted procyanidin C1

DIETARY_SUPPLEMENT

Placebo

Placebo

DIETARY_SUPPLEMENT

PCC1 complex

5 mg of procyanidin C1. Frequency: Administered once daily. Duration: 12 weeks.

Trial Locations (1)

Unknown

University of Geneva, Geneva

Sponsors

Lead Sponsor

Express Rx, Inc
All Listed Sponsors
lead

Express Rx, Inc

INDUSTRY